World Journal of Hepatology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 12

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3363)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-3) series.

Item

Count

PDF

171

WORD

HTML

1511

Tables (1-3)

163

Sum=1938

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

532

Download

893

Sum=1425

Dec 27, 2020 (publication date) through Apr 28, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Higley C, Hsu CC, Smith C, Nadella S, Lalos AT. Safety and efficacy of sofosbuvir/velpatasvir/voxilaprevir in post-liver transplant patients with previous direct-acting antiviral failure: Six case reports. World J Hepatol 2020; 12(12): 1341-1348 [PMID: 33442459 DOI: 10.4254/wjh.v12.i12.1341]
URL:	https://www.wjgnet.com/1948-5182/full/v12/i12/1341.htm

Number	Citing Articles
1	Rishi Arora, Michelle T Martin, Justin Boike, Sonalie Patel. Glecaprevir/pibrentasvir + sofosbuvir for post-liver transplant recurrent hepatitis C virus treatment. World Journal of Hepatology 2023; 15(2): 318-320 doi: 10.4254/wjh.v15.i2.318 Abstract(348) \| Core Tip(217) \| Full Article(HTML)(927) \| Full Article (PDF)-1502K(84) \| Full Article (Word)-102K(39) \| Audio-537K(0) \| Peer-Review Report-455K(27) \| Answering Reviewers-68K(37) \| Times Cited (1) \| Total Visits (2442) \| Open
2	Margherita Saracco, Francesco Tandoi, Francesca Maletta, Roberto Balagna, Renato Romagnoli, Silvia Martini. Early post‐liver transplant use of direct‐acting antivirals in naive and NS5A inhibitor‐experienced HCV patients. Journal of Viral Hepatitis 2023; 30(3): 201 doi: 10.1111/jvh.13782
3	Harshita Katiyar, Mrunal Kamat, Ameet K. Mandot, Amit Goel, Surender Singh, Ajay K. Mishra, Rajani Singh, Prachi Tiwari, Radha K. Dhiman, Samir Shah. Sofosbuvir/Velpatasvir/Voxilaprevir for Hepatitis C Virus Retreatment in Difficult-to-treat Patients: A Real-life Observational Study from India. Journal of Clinical and Experimental Hepatology 2024; 14(2): 101314 doi: 10.1016/j.jceh.2023.101314
4	Jing Xie, Bin Xu, Linlin Wei, Chunyang Huang, Wei Liu. Effectiveness and Safety of Sofosbuvir/Velpatasvir/Voxilaprevir as a Hepatitis C Virus Infection Salvage Therapy in the Real World: A Systematic Review and Meta-analysis. Infectious Diseases and Therapy 2022; 11(4): 1661 doi: 10.1007/s40121-022-00666-0
5	Farina M Hanif, Zain Majid, Nasir Hassan Luck, Abbas Ali Tasneem, Syed Muddasir Laeeq, Muhammed Mubarak. Revolution in the diagnosis and management of hepatitis C virus infection in current era. World Journal of Hepatology 2022; 14(4): 647-669 doi: 10.4254/wjh.v14.i4.647 Abstract(426) \| Core Tip(377) \| Full Article(HTML)(2357) \| Full Article (PDF)-2570K(208) \| Full Article (Word)-624K(129) \| Audio-364K(1) \| Peer-Review Report-659K(52) \| Answering Reviewers-217K(51) \| Times Cited (2) \| Total Visits (6723) \| Open
6	Naveen Kumar, Narendra S. Choudhary. Managing HBV and HCV Infection Pre- and Post-liver Transplant. Journal of Clinical and Experimental Hepatology 2024; 14(2): 101287 doi: 10.1016/j.jceh.2023.09.008